Clorox Company (The) (CLX) Given a $150.00 Price Target by BMO Capital Markets Analysts

Clorox Company (The) (NYSE:CLX) has been assigned a $150.00 target price by equities research analysts at BMO Capital Markets in a research report issued on Thursday. The firm presently has a “buy” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 11.33% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. UBS AG reaffirmed a “sell” rating and issued a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Citigroup Inc. lifted their price target on shares of Clorox Company (The) from $75.00 to $76.00 and gave the company a “neutral” rating in a research note on Friday, April 7th. Vetr downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target for the company. in a research note on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 price target on shares of Clorox Company (The) and gave the company a “hold” rating in a research note on Monday, April 24th. Finally, BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $129.48.

Clorox Company (NYSE:CLX) opened at 134.73 on Thursday. The firm has a market capitalization of $17.35 billion, a price-to-earnings ratio of 26.62 and a beta of 0.40. The company has a 50-day moving average of $134.79 and a 200-day moving average of $133.07. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.22% and a return on equity of 215.99%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the previous year, the firm posted $1.30 earnings per share. The business’s revenue was up 2.9% compared to the same quarter last year. On average, equities analysts forecast that Clorox Company will post $5.69 earnings per share for the current fiscal year.

WARNING: “Clorox Company (The) (CLX) Given a $150.00 Price Target by BMO Capital Markets Analysts” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://transcriptdaily.com/2017/08/04/clorox-company-the-clx-given-a-150-00-price-target-by-bmo-capital-markets-analysts.html.

Several hedge funds and other institutional investors have recently modified their holdings of CLX. Korea Investment CORP boosted its position in Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the period. Crossvault Capital Management LLC boosted its position in Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares during the period. Ameriprise Financial Inc. boosted its position in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the period. Destination Wealth Management boosted its position in Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after buying an additional 3,716 shares during the period. Finally, Janney Capital Management LLC purchased a new position in Clorox Company (The) during the first quarter valued at $216,000. Hedge funds and other institutional investors own 70.56% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)




Receive News & Ratings for Clorox Company (The) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clorox Company (The) and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

one × three =